BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 9070486)

  • 21. [High-dose leucovorin and 5-FU].
    Sasaki T
    Gan To Kagaku Ryoho; 1992 Jul; 19(7):954-62. PubMed ID: 1626951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Modulation of 5-fluorouracil with folinic acid in advanced colorectal cancers. Groupe d'étude et de recherche sur les cancers de l'ovaire et digestifs (GERCOD)].
    de Gramont A; Louvet C; André T; Tournigand C; Raymond E; Molitor JL; Krulik M
    Rev Med Interne; 1997; 18 Suppl 4():372s-378s. PubMed ID: 9365715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controversial issues in 5-fluorouracil infusion use. Dose intensity, treatment duration, and cost comparisons.
    Anderson N; Lokich J
    Cancer; 1992 Aug; 70(4 Suppl):998-1002. PubMed ID: 1638471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.
    Poon MA; O'Connell MJ; Moertel CG; Wieand HS; Cullinan SA; Everson LK; Krook JE; Mailliard JA; Laurie JA; Tschetter LK
    J Clin Oncol; 1989 Oct; 7(10):1407-18. PubMed ID: 2476530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mature results from three large controlled studies with raltitrexed ('Tomudex').
    Cunningham D
    Br J Cancer; 1998; 77 Suppl 2(Suppl 2):15-21. PubMed ID: 9579851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comprehensive review of 5-fluorouracil and leucovorin in patients with metastatic colorectal carcinoma.
    Machover D
    Cancer; 1997 Oct; 80(7):1179-87. PubMed ID: 9317168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Biochemical modulation of 5-fluorouracil by high-dose leucovorin].
    Aiba K
    Gan To Kagaku Ryoho; 1988 Mar; 15(3):392-408. PubMed ID: 3279911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical modulation of 5-FU in systemic treatment of advanced colorectal cancer.
    Grem JL
    Oncology (Williston Park); 2001 Jan; 15(1 Suppl 2):13-9. PubMed ID: 11219972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Sequential methotrexate and 5-fluorouracil].
    Sasaki T
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1907-10. PubMed ID: 8978795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 120-hour 5-fluorouracil (5-FU) continuous infusion (CI) plus BCNU in advanced colorectal cancer.
    Villar-Grimalt A; Candel MT; Delgado F; García-Reinoso J; Sanchis C; Viciano V; Asencio F; Martínez-Abad M; Aguilo J; Sánchez JJ
    Am J Clin Oncol; 1991 Oct; 14(5):387-92. PubMed ID: 1951175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overview of clinical trials using 5-fluorouracil and leucovorin for the treatment of colorectal cancer.
    Arbuck SG
    Cancer; 1989 Mar; 63(6 Suppl):1036-44. PubMed ID: 2645042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current status of clinical studies for colorectal cancer in Taiwan.
    Chen LT; Whang-Peng J
    Clin Colorectal Cancer; 2004 Sep; 4(3):196-203. PubMed ID: 15377403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose continuous infusion 5-fluorouracil and cisplatin: phase II evaluation in advanced colorectal carcinoma.
    LoRusso P; Pazdur R; Redman BG; Kinzie J; Vaitkevicius V
    Am J Clin Oncol; 1989 Dec; 12(6):486-90. PubMed ID: 2686394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chemotherapy of colorectal cancers with metastases].
    de Gramont A; Louvet C; André T; Tournigand C; Raymond E; Krulik M
    Presse Med; 1996 Nov; 25(35):1678-82. PubMed ID: 8977579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Biochemical modulation of 5-FU with interferon].
    Akazawa S
    Gan To Kagaku Ryoho; 1992 Jul; 19(7):963-9. PubMed ID: 1626952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protracted intravenous infusion of 5-fluorouracil in combination treatments. A review.
    Hansen RM
    Acta Oncol; 1991; 30(1):7-10. PubMed ID: 2009187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose fluorouracil: a new perspective in the treatment of colorectal cancer?
    Wils JA
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):126-30. PubMed ID: 1557637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrent Reversible Stroke-Like Encephalopathy After 5-Fluorouracil (5-FU) Chemotherapy: A Case Report and Literature Review.
    Yuwono KA; Hutajulu SH; Gofir A; Nugroho DB
    Am J Case Rep; 2023 Apr; 24():e938437. PubMed ID: 37012696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bimonthly high dose leucovorin and 5-fluorouracil 48-hour continuous infusion in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD).
    Beerblock K; Rinaldi Y; André T; Louvet C; Raymond E; Tournigand C; Carola E; Favre R; de Gramont A; Krulik M
    Cancer; 1997 Mar; 79(6):1100-5. PubMed ID: 9070486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of GERCOD trials of bimonthly leucovorin plus 5-fluorouracil 48-h continuous infusion in advanced colorectal cancer: evolution of a regimen. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD).
    de Gramont A; Louvet C; André T; Tournigand C; Krulik M
    Eur J Cancer; 1998 Apr; 34(5):619-26. PubMed ID: 9713264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.